|
FY2026
9 months to Jun 28, 2026
|
FY2025
12 months to Jun 29, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 25, 2023
|
FY2022
12 months to Jun 26, 2022
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net (loss) income from discontinued operations | |||||
| Net (loss) income | |||||
| Net loss from discontinued operations | |||||
| Net (loss) income from continuing operations | |||||
| Adjustments to reconcile net (loss) income to cash used in operating activities from continuing operations: | |||||
| Non-cash reorganization items | |||||
| Depreciation and amortization | |||||
| Amortization and write-off of deferred financing costs | |||||
| Gain on sale of property | |||||
| Gain on RTP Fab Transfer | |||||
| Goodwill impairment | |||||
| Stock-based compensation | |||||
| Loss (gain) on equity investment | |||||
| Inventory write-off | |||||
| Loss on disposal or impairment of property and equipment | |||||
| Impairment of right-of-use assets | |||||
| Loss on debt extinguishment | |||||
| Gain on contingent cash | |||||
| Amortization of premium on investments, net | |||||
| Change in fair value of liability classified derivative contracts | |||||
| Paid-in-kind interest on long-term debt | |||||
| Deferred income taxes | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued salaries, wages and other liabilities | |||||
| Contract liabilities and distributor-related reserves | |||||
| Net cash used in operating activities of continuing operations | |||||
| Net cash used in operating activities of discontinued operations | |||||
| Cash used in operating activities | |||||
| Investing activities: | |||||
| Purchases of property and equipment | |||||
| Purchases of patent and licensing rights | |||||
| Proceeds from sale of property and equipment | |||||
| Proceeds from sale of MACOM Shares | |||||
| Purchases of short-term investments | |||||
| Proceeds from maturities of short-term investments | |||||
| Proceeds from sale of short-term investments | |||||
| Reimbursement of capital expenditures from incentives and investment credits | |||||
| Proceeds from sale of business | |||||
| Net cash provided by (used in) investing activities of continuing operations | |||||
| Net cash used in investing activities of discontinued operations | |||||
| Cash provided by (used in) investing activities | |||||
| Financing activities: | |||||
| Proceeds from Existing Senior Secured Notes | |||||
| Cash paid for capped call transactions | |||||
| Proceeds from issuance of New Common Stock and Pre-Funded Warrants | |||||
| Payments on Existing Senior Secured Notes | |||||
| Payments of deferred financing costs | |||||
| Payments of equity issuance costs | |||||
| Payment of Contingent Cash | |||||
| Proceeds from contingent consideration | |||||
| Proceeds from issuance of Old Common Stock | |||||
| Adequate protection payments on Existing Senior Secured Notes | |||||
| Tax withholding on vested equity awards | |||||
| Payments on long-term debt borrowings, including finance lease obligations | |||||
| Incentive-related escrow refunds | |||||
| Payment of unused capacity fee on pre-emergence debt | |||||
| Cash (used in) provided by financing activities | |||||
| Effects of foreign exchange changes on cash and cash equivalents | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
Loading...